Thermo Fisher Scientific and Society for Science today announced the winners of the Thermo Fisher Scientific Junior Innovators Challenge (Thermo Fisher JIC), the nation’s leading middle school science ...
SonderCare Launches Impulse™ Essential 39” Residential Comfort Bed ...
OTTAWA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the Hurricane Melissa Appeal to help those impacted by the hurricane in the Caribbean. The Red Cross is working to get ...
In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET on Friday, November 7, 2025. The live audio webcast will be accessible on the Company ...
DurAVR ® THV delivered a favorable hemodynamic profile sustained to one-year, with an EOA of 2.1 + 0.2 cm 2 and a mean pressure gradient (MPG) of 8.6 + 2.6 mmHg. At one-year, clinical safety outcomes ...
A poster on the Effect of VS-01 on systemic inflammation and liver injury in a rat model of endotoxemia will also be presented by GENFIT. While VS-01 has been discontinued in ACLF, pre-clinical ...
BridgeBio to Report Phase 3 Results for Encaleret in ADH1 CALIBRATE Study on Wednesday, October 29th
To access the live webcast for BridgeBio's calls, please visit the “Events and Presentations” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of ...
OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the FDA approval of its 3P™ ...
SOUTH SAN FRANCISCO, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a ...
Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced the closing of its previously announced best efforts public offering (the ...
BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance ...
Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline of small molecule drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results